Pharmacokinetic and pharmacodynamic profile of triethylene glycol indomethacin ester as a new oral prodrug

Journal of Controlled Release

Volumn 41, Issue 3, 1996, Pages 187-193

  Bonina, Francesco P ^a   Montenegro, Lucia ^a   De Caprariis, Paolo ^b   Palagiano, Francesco ^b   Capasso, Anna ^c   Sorrentino, Ludovico ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Indomethacin; Oral prodrugs; Pharmacodynamic; Pharmacokinetic; Triethylene glycol

Indexed keywords

INDOMETACIN; INDOMETACIN DERIVATIVE; INDOMETACIN TRIETHYLENE GLYCOL ESTER; PRODRUG; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CONTROLLED STUDY; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 0030248561     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01319-3     Document Type: Article

References (13)

1. [1] J.G. Lombardino (Ed.), Nonsteroidal Antiinflammatory Drug, Wiley, New York, 1985.
2. [2] H.P. Allan and M. Fletcher, Mechanism of NSAID-induced gastoenteropathy. Drugs 40 (1990) 1-11.
3. [3] F.L. Lanza, G.L. Royer, R.S. Nelson, T.T. Chen, C.E. Seckman and M.F. Rack, The effects of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers. Dig. Dis. Sci. 1979, 24, 823-828.
4. [4] W.S. Beck, H.T. Scneider, K. Dietzel, B. Nuernberg and K. Brune, Gastrointestinal ulceration induced by anti-inflammatory drugs in rats. Arch. Toxicol. 64 (1990) 210-217.
5. [5] H. Bundgaard and N. Nielsen, Glycolamide esters as a novel prodrug type for nonsteroidal antiinflammatory acid drugs. Int. J. Pharm. 43 (1988) 101-110.
6. [6] V.K. Tammara, M.H. Narurkar, A.M. Crider and M.A. Khan, Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen. Pharm. Res. 10 (1993) 1191-1199.
7. [7] M. Mishima, S. Kobayashi, S. Abe and C. Yamato, Metabolic fate of indomethacin farnesil, a prodrug of indomethacin: characteristic biotransformation of indomethacin farnesil in rats. Xenobiotica 20 (1990) 135-146.
8. [8] T. Ogiso, M. Iwaki, T. Kinoshita, T. Tanino and T. Paku, Pharmacokinetics of indomethacin octyl ester (prodrug) and indomethacin produced from the prodrug. J. Pharm. Sci. 83 (1994) 34-37.
9. [9] P. de Caprariis, F. Palagiano, F. Bonina, L. Montenegro, M. D'Amico and F. Rossi, Synthesis and pharmacological evaluation of oligoethylene ester derivatives as indomethacin oral prodrugs. J. Pharm. Sci. 83 (1994) 1578-1581.
10. [10] T. Yoshida, Y. Gomita and R. Oishi, Effect of cigarette smoke on pharmacokinetics of oral, intrarectal, or intravenous indomethacin in rats. Arch. Pharmacol. 344 (1991) 500-504.
11. [11] E. Ranucci, L. Sartore, I. Peroni, R. Latini, R. Bernasconi and P. Ferruti, Pharmacokinetic results on naproxen prodrugs based on poly(ethyleneglycol)s. J. Biomat. Sci. Polymer Edn. 6 (1994) 141-147.
12. [12] F.P. Bonina, L. Montenegro, P. de Caprariis, F. Palagiano, G. Trapani and G. Liso, In vitro and in vivo evaluation of polioxyethylene indomethacin esters as dermal prodrugs. J. Control. Release 34 (1995) 223-232.
13. [13] R. Cecchi, L. Rusconi, M.C. Tanzi, F. Danusso and P. Ferruti, Synthesis and pharmacological evaluation of poly(oxyethylene) derivatives of 4-isobutylphenyl-2-propionic acid (Ibuprofen), J. Med. Chem. 24 (1981) 622-625.